blue | bleu

Neuro National Clinical Trial Training Program

May 23 & 24, 2019

The Montreal Neurological Institute and Hospital’s Clinical Research Unit (CRU), will hold its 4th Annual Neuro National Clinical Trial Training Program on May 23 & 24, 2019 at the Montreal Neurological Institute and Hospital.  Principal investigators, researchers, clinical research coordinators, and representatives from industry are invited to attend this two-day program covering education and training on: clinical trial readiness, medical monitoring, CROs, novel technology in clinical trials, consortium trials, trial design, drug safety, clinical trial outcome measures, and more. Past keynote speakers have included representatives from the pharmaceutical industry, small biotech, CRO representatives, Health Canada, and leading investigators in neurology and rare disease.

The CRU, under the direction of Dr. Angela Genge, is involved in over 100 clinical trials in all fields of neuroscience. Its teams are experienced in Phase I-IV clinical trials, Investigator-initiated trials, bio-banking, and patient registries. The CRU has a unique model, employing specialized personnel in each of the major areas of clinical site management which encompasses finance, ethics, biological sample processing, coordination, nursing, and medical writing.

Registration online here.

For student rates, use promotional code:

NCTTP200

Welcome Event

May 22, 2019
6-10 PM
Pointe-à-Callière Museum, 350 rue Place Royale, Montreal Cocktail - Dinatoire + Museum tour

Program Day 1

8

Continental Breakfast

8:30

Welcoming Remarks
Angela Genge, MD, FRCP Director, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada

8:45 Development Path of the Raman Probe Technology
Christopher Kent, PhD President & CEO
ODS Medical, Canada
9:15 Modelling disorders of the brain through stem cells
Thomas Durcan, PhD
Assistant Professor
Montreal Neurological Institute and Hospital, Canada
9:45 A tale of two worlds : investment & entrepreneurship in diagnostics
Marie-Claude Marchand, BSc, MBA
Senior Advisor
TVM Life Science Management Inc., Canada
10:15 Panel - Q & A
10:30 Refreshment break
10:45 Consortiums & Clinical Trials
Leonard van den Berg, MD
Professor of Neurology
Director Netherlands ALS Center
Chair of ENCALS University Medical Center
Utrecht, Netherlands
11:15

Oncology Trial Design
Robert Schott, MD, MPH, FAAC
Chief Medical Officer
Lilly - Chorus, USA

11:45 Challenges of a pharmaceutical start-up
Jim Callaway, PhD
CEO KalGene Pharmaceuticals, Canada
12:15 Panel - Q & A
12:30 Lunch
13:30 Medical Monitoring in Clinical Trials
Jinsy Andrews, MD, MSc.
Assistant Professor of Neurology
Columbia University, USA
14 Drug Safety Monitoring
Joshua Galanter, MD, MAS
Safety Science
Associated Medical Director
LEAD/Early Development Safety Genentech Inc., USA
14:30 Ethics of Al & Gene Therapy Research in Medicine
Marie Hirtle, LLB, LLM
Manager Center of Applied Ethics - MUHC, Canada
15 Panel Q & A
15:15 Refreshment break
15:30 CIHR Initiatives that support drug development
Martine Lafrance, PhD
Manager of Program Design & Delivery Programs
Canadian Institutes of Health Research (CIHR), Canada
16

Patients before costs: A balanced approach to drug development
Daria Wojtal, PhD
Director of Research
Muscular Dystrophy Canada

Marie-Hélène Bolduc Director of Mission Muscular Dystrophy Canada

16:30

Health Canada & Gene Therapy Trials
Nadine Kolas, MD
Senior Policy Analyst
Policy & International Collaboration
Health Canada

17 Panel Q & A
17:15 Closing Remarks & Discussion
Dr. Angela Genge
18 Dinner - Joiea Sociale, 656 Wellington Street, Montréal

Program Day 2

8:30

Continental Breakfast

9 Welcoming Remarks
Angela Genge, MD, FRCP
Director, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada
9:15 Drug Development in the Digital Age - A Perspective on Neuroscience
Norman Putzki, MD, PhD
Vice President Global Drug Development
Novartis Pharma AG, USA
9:45 CRO-Sponsor Relationships
Ignazio Di Giovanna, PhD
Vice President, European Operations
Atlantic Research Group
10:15 New tech in trials
Jesse Cedarbaum, MD
Vice President, Neurology Early Clinical Development
Biogen Idec, USA
10:45 Panel Q & A
11 Refreshment break
11:15

Phase 1 Units in Neuroscience
Angela Genge, MD, FRCP
Director, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada

Kristiana Salmon, BSc, EMBA
Assistant Manager, Clinical Research Unit
Montreal Neurological Institute and Hospital, Canada

12:30

Closing Remarks
Dr. Angela Genge

12:35 Lunch & Networking

Hotels

Hotel 10

Hotel 10 is a downtown Montreal boutique hotel located at the heart of Montreal’s entertainment district. Hotel 10 provides an exquisite experience with its personalized service, stellar amenities, and interior design featuring locally-made artwork. You are invited to feel at home and experience Montreal moments the way they were intended.

To book with Hotel 10, please mention your guest affiliation with The Montreal Neurological Institute, in order to benefit from the preferential rate at the moment of your reservation. Individual reservation can be made by phone locally at +1(514) 843 6000 or toll free at +1 866 744 6346. Reservations can also be made through email by writing to reservations [at] hotel10montreal.com. The last-day with the preferential booking rate is the 7th of April, 2019. We encourage you to book as soon as possible, given the limited amount of rooms offered at the preferred rate.

Hotel 10 offers rooms available from the 22nd of May (arrival date) up to the 25th of May (departure date). The rate per night starts at 199$ for a Privilege King room (subject to additional tax fees) with one king bed for single or double occupancy, and can be booked up to quadruple occupancy with 35$ extra per additional person. Complimentary services include Wi-Fi connection . The cancellation policy is 72 hours prior to arrival date.


Chateau Versailles

Offering a cozy atmosphere, historic splendour, and artful surroundings in downtown Montreal, Chateau Versailles is a historic hotel with a seamless blend of sophistication and comfort.

Individual reservation can be made by phone at +1 888 933 8111 or through email by writing to reservations [at] versailleshotels.com. Please mention the group code MUE22S in proceeding with either mode of reservation. The last-day with the preferential booking rate is on the 22nd of April, 2019.

We encourage you to book as soon as possible, given the limited amount of rooms offered at the preferred rate.

Chateau Versailles offers rooms available from the 22nd of May up to the 25th of May. The rate per night starts at 179$ for a Deluxe 1 bed or a Deluxe Fireplace King / Queen at 189$ (subject to additional tax fees, single or double occupancy). Both rooms can be booked up to quadruple occupancy with 20 $ extra per additional person. Complimentary services include Wi-Fi connection and an expanded continental buffet breakfast served daily in Le Boudoir. Check in time is at 3:00 PM and check out time is at 12:00 PM the following day. Luggage handling is 6$ per person round trip, with a maximum of 2 luggage pieces per person. The hotel cancellation policy is 21 days prior to arrival.


McGill University has agreements for special rates with several other downtown hotels.

Follow this link to see the selection.

Organizing Committee

Angela Genge

Maxime Boutin-Caron

Debbie Rashcovsky

Kristiana Salmon

Contact

Debbie Rashcovsky
Events Officer

Director's Office
Montreal Neurological Institute
3801 University Street, room 640
Montreal, Quebec H3A 2B4

Tel: 514-398-6047  Fax: 514-398-8248
Email: debbie.rashcovsky [at] mcgill.ca

The Montreal Neurological Institute & Hospital is a McGill University research and teaching institute; delivering the highest quality of care to patients, as part of the Neuroscience Mission of the McGill University Health Centre. The Neuro is proud to be a Killam Institution, supported by the Killam Trusts.